{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T02:14:57Z","timestamp":1783736097118,"version":"3.55.0"},"reference-count":8,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>Selective inhibition of interleukin (IL)-31 led not only to rapid relief of severe pruritus but also to dramatic improvement of inflammatory skin lesions in pruriginosa-type recessive dystrophic epidermolysis bullosa in a boy in early adolescence. While IL-31 is well recognized as a central mediator of itch, this clinical course suggests that IL-31 functions as a disease-amplifying switch linking immune activation, scratching behaviour and cutaneous damage. Interrupting this pathway appeared to collapse the itch\u2013scratch cycle itself, resulting in sustained clinical improvement beyond symptomatic itch control.<\/jats:p>","DOI":"10.1093\/ced\/llag186","type":"journal-article","created":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T11:33:08Z","timestamp":1777203188000},"source":"Crossref","is-referenced-by-count":0,"title":["Possible involvement of interleukin-31 in pruriginosa-type recessive dystrophic epidermolysis bullosa: a positive response to nemolizumab"],"prefix":"10.1093","author":[{"given":"Nana","family":"Ebi","sequence":"first","affiliation":[{"name":"Department of Dermatology, Kyoto University Graduate School of Medicine , Kyoto ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0683-719X","authenticated-orcid":false,"given":"Toshiaki","family":"Kogame","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Kyoto University Graduate School of Medicine , Kyoto ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akemi","family":"Ishida-Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Asahikawa Medical University , Hokkaido ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eijiro","family":"Akasaka","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Hirosaki University School of Medicine , Aomori ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0773-0554","authenticated-orcid":false,"given":"Kenji","family":"Kabashima","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Kyoto University Graduate School of Medicine , Kyoto ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"key":"2026071021461093800_llag186-B1","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1038\/jid.2014.500","article-title":"Peripheral neuro-immune pathology in recessive dystrophic epidermolysis bullosa","volume":"135","author":"Mack","year":"2015","journal-title":"J Invest Dermatol"},{"key":"2026071021461093800_llag186-B2","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.immuni.2025.03.018","article-title":"The sensory neuroimmune frontier","volume":"58","author":"Kim","year":"2025","journal-title":"Immunity"},{"key":"2026071021461093800_llag186-B3","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/jdv.19738","article-title":"Mechanism underlying pruritus in recessive dystrophic epidermolysis bullosa: role of interleukin-31 from mast cells and macrophages","volume":"38","author":"Lee","year":"2024","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026071021461093800_llag186-B4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/jdv.17671","article-title":"Dystrophic epidermolysis bullosa pruriginosa: a new case series of a rare phenotype unveils skewed Th2 immunity","volume":"36","author":"Darbord","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026071021461093800_llag186-B5","doi-asserted-by":"crossref","first-page":"1648732","DOI":"10.3389\/fmed.2025.1648732","article-title":"Effective treatment of dystrophic epidermolysis bullosa pruriginosa with tofacitinib","volume":"12","author":"Sun","year":"2025","journal-title":"Front Med (Lausanne)"},{"key":"2026071021461093800_llag186-B6","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1056\/NEJMoa1917006","article-title":"Trial of nemolizumab and topical agents for atopic dermatitis with pruritus","volume":"383","author":"Kabashima","year":"2020","journal-title":"N Engl J Med"},{"key":"2026071021461093800_llag186-B7","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jdermsci.2015.09.011","article-title":"Japanese recurrent mutation c.6216+5G&gt;T in COL7A1 leads to a mild phenotype of dystrophic epidermolysis bullosa","volume":"80","author":"Masunaga","year":"2015","journal-title":"J Dermatol Sci"},{"key":"2026071021461093800_llag186-B8","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41423-025-01261-2","article-title":"Type 2 immunity in allergic diseases","volume":"22","author":"Ogulur","year":"2025","journal-title":"Cell Mol Immunol"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llag186\/68173585\/llag186.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llag186\/68173585\/llag186.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T01:46:19Z","timestamp":1783734379000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/advance-article\/doi\/10.1093\/ced\/llag186\/8663831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":8,"URL":"https:\/\/doi.org\/10.1093\/ced\/llag186","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"value":"0307-6938","type":"print"},{"value":"1365-2230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"article-number":"llag186"}}